Wird geladen...
Diabetes and risk of infections with immunomodulator therapy in inflammatory bowel diseases
BACKGROUND: Infections are an important concern in patients using immunosuppressive therapy for their inflammatory bowel disease (IBD). Diabetes affects nearly 10% of Americans. Whether it confers an additional risk with immunosuppression in IBD has not been examined previously. AIM: To examine the...
Gespeichert in:
| Veröffentlicht in: | Aliment Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4420684/ https://ncbi.nlm.nih.gov/pubmed/25864945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13195 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|